Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy

被引:33
|
作者
Toledo, Gabriela [1 ,2 ]
Ochoa, Carol Y. [1 ]
Farias, Albert J. [3 ]
机构
[1] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA
[2] UCL, UCL Great Ormond St Inst Child Hlth, London, England
[3] Univ Southern Calif, Gehr Family Ctr Hlth Syst Sci, Dept Prevent Med, Los Angeles, CA 90007 USA
关键词
Breast cancer; Religion; Spirituality; Adjuvant endocrine therapy; Psychosocial adjustment; QUALITY-OF-LIFE; PSYCHOLOGICAL ADJUSTMENT; WOMEN; TAMOXIFEN; ADHERENCE; BENEFIT; DISCONTINUATION; ASSOCIATION; PREDICTORS; STRESS;
D O I
10.1007/s00520-020-05722-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Distress from being diagnosed with breast cancer can impact a woman's decision to continue taking adjuvant endocrine therapy (AET). The purpose of this study is to explore how religion and/or spirituality influence women's psychosocial adjustment to breast cancer and subsequent symptom management among women on active AET. Methods Semi-structured in-depth interviews were conducted with breast cancer survivors (n = 19) from California and Texas. Interview questions prompted discussion about AET and how women adjusted to a breast cancer diagnosis and treatment with AET. Interview transcripts were analyzed with a deductive grounded theory approach, and an inductive constant comparison approach was used to identify the sources of religion and spirituality. Results Religion supported women in their psychosocial adjustment to breast cancer by offering them a sense of purpose and meaning in life. It helped women make sense of their AET treatment as they persisted with it despite experiencing adverse side-effects. Spirituality played a prominent role in women's mental and physical wellbeing by facilitating positive and calm attitudes, which lessened women's fear during their cancer diagnosis and treatment. Conclusion We identified that religion and/or spirituality helps women with their adjustment to breast cancer and influences their continued use and management of side-effects from AET. Implications for breast cancer survivors This study illustrates the importance of developing meaning-centered interventions that harness religion and spirituality to help women cope with AET. Our findings support the development of interventions that work to enhance AET persistence among breast cancer survivors.
引用
收藏
页码:3017 / 3024
页数:8
相关论文
共 50 条
  • [31] ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY OF BREAST-CANCER
    HEUSON, JC
    PARIDAENS, R
    LOUVAIN MEDICAL, 1982, 101 (10): : 617 - 626
  • [32] Compliance and persistence of endocrine adjuvant breast cancer therapy
    Uwe Güth
    Mary Elizabeth Myrick
    Nerbil Kilic
    Serenella Eppenberger-Castori
    Seraina Margaretha Schmid
    Breast Cancer Research and Treatment, 2012, 131 : 491 - 499
  • [33] Adjuvant Endocrine Therapy and Bone Health in Breast Cancer
    Clines, Gregory A.
    Choksi, Palak
    Van Poznak, Catherine
    CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (05) : 263 - 273
  • [34] Postmenopausal breast cancer. Adjuvant endocrine therapy
    Fischer, D.
    Thill, M.
    Roeder, K.
    Buendgen, N.
    Diedrich, K.
    Dittmer, C.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2010, 8 (01): : 30 - 34
  • [35] Adjuvant Endocrine Therapy for Premenopausal Breast Cancer REPLY
    Francis, Prudence A.
    Pagani, Olivia
    Regan, Meredith M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (17): : 1684 - 1685
  • [36] Male Breast Cancer and Adherence to Adjuvant Endocrine Therapy
    Lee, Inyoung
    Lee, Wan-Ju
    Calip, Gregory S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 189 - 190
  • [37] ADJUVANT ENDOCRINE THERAPY REGIMENS IN BREAST-CANCER
    JAKESZ, R
    HAUSMANINGER, H
    WIENER KLINISCHE WOCHENSCHRIFT, 1984, 96 (13) : 492 - 499
  • [38] Adjuvant endocrine therapy in premenopausal women with breast cancer
    Antonio González Martín
    Susana de la Cruz
    Raúl Márquez
    Breast Cancer Research and Treatment, 2010, 123 : 43 - 47
  • [39] Evolution of endocrine adjuvant therapy for early breast cancer
    Lonning, Per Eystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 : S19 - S30
  • [40] Adjuvant endocrine therapy for premenopausal women with breast cancer
    Puhalla, Shannon
    Brufsky, Adam
    Davidson, Nancy
    BREAST, 2009, 18 : S122 - S130